What is the address of NEW OFIR?

The registered office of NEW OFIR is located at Schipvaartstraat 4, 3000 Leuven.

Is NEW OFIR still active?

Yes. According to the CBE (29 October 2026) NEW OFIR is active, legal situation “Normale toestand”, started on 24 December 1992.

Is NEW OFIR registered on Peppol?

Yes, NEW OFIR is registered on the Peppol network with ID 0208:0449037348.

What is the enterprise number of NEW OFIR?

The enterprise number of NEW OFIR is BE0449037348.

When was NEW OFIR founded?

NEW OFIR was founded on 24 December 1992.

Who are the directors of NEW OFIR?

According to the 2025 annual accounts, the directors of NEW OFIR are: DR. SYLVIE GORDTS BV, Dr. Vermeulen - Dr. Segaert BV.

Is NEW OFIR a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 24 December 1992; 5 annual accounts filed, latest fiscal year 2025; 2 directors known from the annual account.

How much profit did NEW OFIR make in 2025?

NEW OFIR posted a profit after taxes of € 1 in financial year 2025.

What is the revenue of NEW OFIR?

As a small company, NEW OFIR is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 298.

NEW OFIR (Private Limited) - Leuven - BE0449037348

Dossier NEW OFIR, printed on 29 October 2026 from databakkes.be/en/0449037348/new-ofir. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

NEW OFIR from Leuven, company number BE0449037348, closed financial year 2025 with a result of € 1 after tax. For that financial year NEW OFIR recorded a gross margin of € 298 and equity of € 57,212. Compared with financial year 2024, the result moved from € 8,630 to € 1. The company is profitable. The buffer is growing. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on June 22, 2026.

What it is worth Growing

€ 57,212

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 1

▼ € 8,629 vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 145,071

▲ 32% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € 48,449.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 395

▲ 11% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 8,640 Gross margin 2022: € 8,640 First fiscal year in the series	€ -24,845 Gross margin 2023: € -24,845 ▼ € 33,485 vs 2022 (€ 8,640) Unfavourable step	€ 8,894 Gross margin 2024: € 8,894 ▲ € 33,739 vs 2023 (€ -24,845) Favourable step	€ 298 Gross margin 2025: € 298 ▼ 97% vs 2024 (€ 8,894) Unfavourable step	▼ 97%
Profit after taxes	€ 6,091 Profit after taxes 2022: € 6,091 First fiscal year in the series	€ -25,330 Profit after taxes 2023: € -25,330 ▼ € 31,421 vs 2022 (€ 6,091) Unfavourable step	€ 8,630 Profit after taxes 2024: € 8,630 ▲ € 33,960 vs 2023 (€ -25,330) Favourable step	€ 1 Profit after taxes 2025: € 1 ▼ € 8,629 vs 2024 (€ 8,630) Unfavourable step	▼ € 8,629
Equity	€ 73,911 Equity 2022: € 73,911 First fiscal year in the series	€ 48,582 Equity 2023: € 48,582 ▼ 34% vs 2022 (€ 73,911) Unfavourable step	€ 57,212 Equity 2024: € 57,212 ▲ 18% vs 2023 (€ 48,582) Favourable step	€ 57,212 Equity 2025: € 57,212 Unchanged (€ 57,212) Favourable step
Total debts	€ 197,127 Total debts 2022: € 197,127 First fiscal year in the series	€ 98,792 Total debts 2023: € 98,792 ▼ 50% vs 2022 (€ 197,127) Favourable step	€ 132,564 Total debts 2024: € 132,564 ▲ 34% vs 2023 (€ 98,792) Unfavourable step	€ 317,473 Total debts 2025: € 317,473 ▲ 139% vs 2024 (€ 132,564) Unfavourable step	▲ 139%
Cash	€ 57,359 Cash 2022: € 57,359 First fiscal year in the series	€ 46,446 Cash 2023: € 46,446 ▼ 19% vs 2022 (€ 57,359) Unfavourable step	€ 109,958 Cash 2024: € 109,958 ▲ 137% vs 2023 (€ 46,446) Favourable step	€ 145,071 Cash 2025: € 145,071 ▲ 32% vs 2024 (€ 109,958) Favourable step	▲ 32%
Retained profit	€ 65,148 Retained profit 2022: € 65,148 First fiscal year in the series	€ 39,819 Retained profit 2023: € 39,819 ▼ 39% vs 2022 (€ 65,148) Unfavourable step	€ 48,449 Retained profit 2024: € 48,449 ▲ 22% vs 2023 (€ 39,819) Favourable step	€ 48,449 Retained profit 2025: € 48,449 Unchanged (€ 48,449) Favourable step
Balance sheet total	€ 271,038 Balance sheet total 2022: € 271,038 First fiscal year in the series	€ 147,374 Balance sheet total 2023: € 147,374 ▼ 46% vs 2022 (€ 271,038) Unchanged	€ 189,776 Balance sheet total 2024: € 189,776 ▲ 29% vs 2023 (€ 147,374) Unchanged	€ 374,685 Balance sheet total 2025: € 374,685 ▲ 97% vs 2024 (€ 189,776) Unchanged	▲ 97%

Key figures of NEW OFIR, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to NEW OFIR?

What happened at NEW OFIR in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jun 22, 2026 New annual accounts for financial year 2025: profit of € 1 (▼ € 8,629 vs 2024). Source: NBB ↗
2024 Dr. Vermeulen - Dr. Segaert BV became a director. NBB
Feb 1, 2017 New establishment in Leuven. KBO
Dec 24, 1992 Start of the company according to the CBE. KBO

In short

From € 6,091 profit in 2022 to € 1 profit in 2025.

Paid € 2,259 in corporate taxes since 2022.

Best year ever: 2024, with € 8,630 profit.

Original PDFs at the National Bank ↗

Management

Dr. Marion Valkenburg 14.9%

The stake of Dr. Marion Valkenburg comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.

NEW OFIR

Life Expert Centre 5%

Behind NEW OFIR are DR. SYLVIE GORDTS BV and Dr. Vermeulen - Dr. Segaert BV. The shares are held by Dr. Marion Valkenburg (14.9%). It owns 5% of Life Expert Centre itself.

Directors

According to the 2025 annual accounts

DR. SYLVIE GORDTS BV

Director · represented by Sylvie Gordts

Also active at: NEW LIFE

Dr. Vermeulen - Dr. Segaert BV

Director · represented by Isabelle Segaert

Also active at: NEW LIFE

since 2024

Shareholders

Dr. Marion Valkenburg

14.9%

Participations

Life Expert Centre

Establishments

Establishment units

Physical locations of this company

Registered office

Schipvaartstraat 4

3000 Leuven

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 7 companies are registered at this address.

All companies at this address →

Leuven Institute for Fertility and Embryology

LIFE EXPERT CENTRE same network

€ 353,935 gross margin · 2025

Life Leuven

NEW LIFE same network

€ 1,070 gross margin · 2025

Maatschap CV LEC

+2 more

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0449.037.348
VAT number: BE 0449.037.348
Registered office: Schipvaartstraat 4, 3000 Leuven
Names & denominations: NEW OFIR
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 24 December 1992
Peppol: Active · Active since 1 Jan 2001

View on CBE Public ↗ Annual accounts (NBB) ↗